Farries T C, Steuer K L, Atkinson J P
Howard Hughes Medical Institute Laboratories, Washington University School of Medicine, St Louis, MO 63110.
Immunol Today. 1990 Mar;11(3):78-80. doi: 10.1016/0167-5699(90)90031-4.
The classical pathway of complement activation is a highly specific and amplifiable effector system responding to recognition of foreign antigens by antibody. It comprises a group of well characterized proteins in mammalian plasma. There are many similarities with the alternative pathway of complement activation, which suggests that they have a common evolutionary origin. Both pathways have homologous components, use related activation and regulatory mechanisms, result in the release of the anaphylatoxins C3a and C5a, and deposit C3b onto activating surfaces. This fixed C3b then becomes the focus of further immune reactions, involving either the lytic complement components or C3b receptors on effector cells. Phylogenetic data indicate that the alternative pathway is the older, and that the classical pathway evolved from it. Here Timothy Farries and colleagues review this evolutionary process and present a possible sequence of events that is suggested by recent functional data from their laboratory.
补体激活的经典途径是一个高度特异性且可放大的效应系统,对抗体识别外来抗原作出反应。它由哺乳动物血浆中一组特性明确的蛋白质组成。与补体激活的替代途径有许多相似之处,这表明它们有共同的进化起源。两条途径都有同源成分,使用相关的激活和调节机制,导致过敏毒素C3a和C5a的释放,并将C3b沉积在激活表面。这种固定的C3b随后成为进一步免疫反应的焦点,涉及溶解补体成分或效应细胞上的C3b受体。系统发育数据表明替代途径更为古老,经典途径是由其进化而来。在此,蒂莫西·法里斯及其同事回顾了这一进化过程,并根据他们实验室最近的功能数据提出了一个可能的事件序列。